Celltrion
068270.KS
#933
Rank
S$34.39 B
Marketcap
S$149.98
Share price
3.15%
Change (1 day)
-0.41%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): S$2.46

According to Celltrion 's latest financial reports the company's current EPS (TTM) is S$2.45. an increase over its 2024 EPS that were of S$1.59.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025S$4.20163.66%
2024S$1.59-53.73%
2023S$3.45-2.08%
2022S$3.52-11.72%
2021S$3.992.03%
2020S$3.9182.8%
2019S$2.1418.31%
2018S$1.81-36.33%
2017S$2.84161.25%
2016S$1.092.86%
2015S$1.0617.84%
2014S$0.905.87%
2013S$0.85-70.85%
2012S$2.90134.09%
2011S$1.2443.59%
2010S$0.8674.49%
2009S$0.50317.8%
2008S$0.12-71.7%
2007S$0.42